Thyroglobulin Antibody (Tg-Ab) Quantitative
This biomarker measures the levels of thyroglobulin antibodies in the blood, which can indicate autoimmune thyroid disorders.
Tg-Ab levels help diagnose autoimmune thyroid conditions like Hashimoto's thyroiditis.
Key facts at a glance
- Units
- IU/mL
- Clinical utility
- diagnostic
- Result kind
- quantitative
- FDA-cleared
- Roche Anti-Tg Quant, Abbott Anti-Tg Quant
Thyroglobulin antibodies (Tg-Ab) are produced by the immune system and target thyroglobulin, a protein essential for thyroid hormone production. Elevated levels of Tg-Ab can signify an autoimmune response against the thyroid gland.
The quantitative measurement of Tg-Ab is crucial for diagnosing and monitoring conditions such as Hashimoto's thyroiditis and Graves' disease. It is often used in conjunction with other thyroid function tests to provide a comprehensive assessment.
Normal reference ranges for Tg-Ab are typically between 0–20 IU/mL. Results above this range may indicate the presence of an autoimmune thyroid disorder, prompting further investigation and management.
Frequently asked questions
What conditions can cause elevated Tg-Ab levels?
How is the Tg-Ab test performed?
Sources
- 1
- 2Mayo ClinicSource
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy